Fluorouracil/Leucovorin/Oxaliplatin/Tislelizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of fluorouracil, leucovorin, oxaliplatin, and tislelizumab that may be used in the treatment of esophageal and esophagogastric junction cancers, and gastric cancer.

**Synonyms:** - Fluorouracil-Leucovorin-Oxaliplatin-Tislelizumab - Fluorouracil/Leucovorin/Oxaliplatin Plus Tislelizumab-jsgr - Fluorouracil/Leucovorin/Oxaliplatin/Tevimbra - Fluorouracil/Leucovorin/Oxaliplatin/Tislelizumab - Fluorouracil/Leucovorin/Oxaliplatin/Tislelizumab-jsgr Regimen